Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Novak

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Plos One|August 11, 2012
N-terminal domain of nuclear IL-1α shows structural similarity to the C-terminal domain of Snf1 and binds to the HAT/core module of the SAGA complexBlanka Zamostna, Josef Novak, Vaclav Vopalensky, et al.
Cytoskeleton (Hoboken, N.J.)|September 25, 2024
Tristetraprolin affects invasion-associated genes expression and cell motility in triple-negative breast cancer modelAnastasiia Hubiernatorova, Josef Novak, Michaela Vaskovicova, et al.
Micromachines|January 8, 2025
Insulator Material Deposited with Molybdenum Disulphide Prospective for Sensing ApplicationMariapompea Cutroneo, Petr Malinsky, Josef Novak, et al.
Neuro-Oncology Advances|June 1, 2026
Cellular senescence escape and antiviral response discriminate glioblastoma from lower-grade gliomasDominika Maurencova, Michaela Sadibolova, Monika Zarska, et al.
Colloids and Surfaces. B, Biointerfaces|August 2, 2024
Photothermal induction of pyroptosis in malignant glioma spheroids using (16-mercaptohexadecyl)trimethylammonium bromide-modified cationic gold nanorodsMonika Zarska, Ondrej Novak, Tereza Jakubcova, et al.
Elife|October 10, 2024
Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartmentAlexandra Urbancokova, Terezie Hornofova, Josef Novak, et al.
Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.
Molecular Oncology|April 27, 2025
Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescenceZuzana Liblova, Dominika Maurencova, Barbora Salovska, et al.
Bioorganic Chemistry|April 23, 2026
The structure-activity relationship study of torkinib derivatives as mTOR inhibitors with senolytic and STAT3 inhibitory activitiesPatrik Oleksak, David Rysanek, Marketa Vancurova, et al.
Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|August 11, 2012
N-terminal domain of nuclear IL-1α shows structural similarity to the C-terminal domain of Snf1 and binds to the HAT/core module of the SAGA complexBlanka Zamostna, Josef Novak, Vaclav Vopalensky, et al.
Cytoskeleton (Hoboken, N.J.)|September 25, 2024
Tristetraprolin affects invasion-associated genes expression and cell motility in triple-negative breast cancer modelAnastasiia Hubiernatorova, Josef Novak, Michaela Vaskovicova, et al.
Micromachines|January 8, 2025
Insulator Material Deposited with Molybdenum Disulphide Prospective for Sensing ApplicationMariapompea Cutroneo, Petr Malinsky, Josef Novak, et al.
Neuro-Oncology Advances|June 1, 2026
Cellular senescence escape and antiviral response discriminate glioblastoma from lower-grade gliomasDominika Maurencova, Michaela Sadibolova, Monika Zarska, et al.
Colloids and Surfaces. B, Biointerfaces|August 2, 2024
Photothermal induction of pyroptosis in malignant glioma spheroids using (16-mercaptohexadecyl)trimethylammonium bromide-modified cationic gold nanorodsMonika Zarska, Ondrej Novak, Tereza Jakubcova, et al.
Elife|October 10, 2024
Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartmentAlexandra Urbancokova, Terezie Hornofova, Josef Novak, et al.
Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.
Molecular Oncology|April 27, 2025
Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescenceZuzana Liblova, Dominika Maurencova, Barbora Salovska, et al.
Bioorganic Chemistry|April 23, 2026
The structure-activity relationship study of torkinib derivatives as mTOR inhibitors with senolytic and STAT3 inhibitory activitiesPatrik Oleksak, David Rysanek, Marketa Vancurova, et al.
Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.
Pageof 2